Immunization with Schistosoma mansoni 22.6kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine

Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucl. Acids Res., 25, 3389, 10.1093/nar/25.17.3389 Bergquist, 1995, Schistosomiasis vaccine development: approaches and prospects, Mem. Inst. Oswaldo Cruz, 90, 221, 10.1590/S0074-02761995000200017 Bergquist, 1998, Schistosomiasis vaccine development: progress and prospects, Mem. Inst. Oswaldo Cruz, 93, 95, 10.1590/S0074-02761998000700013 Bergquist, 2002, Schistosomiasis: from risk assessment to control, Trends Parasitol., 18, 309, 10.1016/S1471-4922(02)02301-2 Bergquist, 2002, Blueprint for schistosomiasis vaccine development, Acta Trop., 82, 183, 10.1016/S0001-706X(02)00048-7 Boros, 1989, Immunopathology of Schistosoma mansoni infection, Clin. Microbiol. Rev., 2, 250, 10.1128/CMR.2.3.250 Brito, 2000, Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding protein, Parasite Immunol., 22, 41 Coulson, 1997, The radiation-attenuated vaccine against schistosomes in animal models: paradigm for human vaccine?, Adv. Parasitol., 39, 271, 10.1016/S0065-308X(08)60048-2 Coulson, 1997, Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes, Infect. Immun., 65, 42, 10.1128/IAI.65.1.42-48.1997 Dunne, 1997, The isolation of a 22kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection, Parasite Immunol., 19, 79, 10.1046/j.1365-3024.1997.d01-186.x Fonseca, 2004, IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14−kDa Schistosoma mansoni fatty acid-binding protein through an IFN-γ and TNF-α dependent pathway, Vaccine, 22, 503, 10.1016/j.vaccine.2003.07.010 Franco, 1997, Evaluation of cDNA libraries from different developmental stages of Schistosoma mansoni for production of expressed sequence tags (ESTs), DNA Res., 4, 231, 10.1093/dnares/4.3.231 Harder, 2002, Chemotherapeutic approaches to schistosomes: current knowledge and outlook, Parasitol. Res., 88, 395, 10.1007/s00436-001-0588-x Jankovic, 1999, Optimal vaccination against Schistosoma mansoni requires the induction of both B cell and IFNγ dependent effector mechanisms, J. Immunol., 162, 345, 10.4049/jimmunol.162.1.345 Jeffs, 1991, Molecular cloning and characterization of 22-kilodalton adult S. mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes, Mol. Biochem. Parasitol., 46, 159, 10.1016/0166-6851(91)90209-O Klinman, 2004, Use of CpG oligodeoxynucleotides as immune adjuvants, Immunol. Rev., 199, 201, 10.1111/j.0105-2896.2004.00148.x Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 Li, 2000, Immunogenicity and immunolocalization of the 22.6kDa antigen of Schistosoma japonicum, Parasite Immunol., 22, 415, 10.1046/j.1365-3024.2000.00319.x McManus, 1999, The search for a vaccine against schistosomiasis – a difficult path but an achievable goal, Immunol. Rev., 171, 149, 10.1111/j.1600-065X.1999.tb01346.x Martin, 1998, Is IgG2a a good Th1 marker in mice?, Immunol. Today, 19, 49, 10.1016/S0167-5699(97)87499-3 Minard, 1978, Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae, Am. J. Trop. Med. Hyg., 27, 76, 10.4269/ajtmh.1978.27.76 Santiago, 1998, Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides, Allergy Immunol., 117, 94, 10.1159/000023995 Towbin, 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA, 76, 4350, 10.1073/pnas.76.9.4350 van der Werf, 2003, Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa, Acta Trop., 86, 125, 10.1016/S0001-706X(03)00029-9 Webster, 1996, Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from schistosomiasis mansoni adult worms are associated with low intensities of reinfection after treatment, Infect. Immun., 64, 4042, 10.1128/IAI.64.10.4042-4046.1996 Wilson, 1996, Impaired immunity and altered pulmonary response in mice with a disrupted interferon-γ receptor gene exposed to the irradiated Schistosoma mansoni vaccine, Immunology, 87, 275, 10.1046/j.1365-2567.1996.465550.x Wynn, 2000, Defining a schistosomiasis vaccination strategy – is it really Th1 versus Th2?, Parasitol. Today, 16, 497, 10.1016/S0169-4758(00)01788-9